BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 11016935)

  • 1. Altered cytokine production in mice lacking P2X(7) receptors.
    Solle M; Labasi J; Perregaux DG; Stam E; Petrushova N; Koller BH; Griffiths RJ; Gabel CA
    J Biol Chem; 2001 Jan; 276(1):125-32. PubMed ID: 11016935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response.
    Labasi JM; Petrushova N; Donovan C; McCurdy S; Lira P; Payette MM; Brissette W; Wicks JR; Audoly L; Gabel CA
    J Immunol; 2002 Jun; 168(12):6436-45. PubMed ID: 12055263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity.
    Perregaux D; Gabel CA
    J Biol Chem; 1994 May; 269(21):15195-203. PubMed ID: 8195155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priming of macrophages with lipopolysaccharide potentiates P2X7-mediated cell death via a caspase-1-dependent mechanism, independently of cytokine production.
    Le Feuvre RA; Brough D; Iwakura Y; Takeda K; Rothwell NJ
    J Biol Chem; 2002 Feb; 277(5):3210-8. PubMed ID: 11706016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maturation and release of interleukin-1beta by lipopolysaccharide-primed mouse Schwann cells require the stimulation of P2X7 receptors.
    Colomar A; Marty V; Médina C; Combe C; Parnet P; Amédée T
    J Biol Chem; 2003 Aug; 278(33):30732-40. PubMed ID: 12796490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release.
    Elssner A; Duncan M; Gavrilin M; Wewers MD
    J Immunol; 2004 Apr; 172(8):4987-94. PubMed ID: 15067080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood.
    Perregaux DG; McNiff P; Laliberte R; Conklyn M; Gabel CA
    J Immunol; 2000 Oct; 165(8):4615-23. PubMed ID: 11035104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo evidence for a role of the P2X7 receptor in the release of IL-1 beta in the murine brain.
    Mingam R; De Smedt V; Amédée T; Bluthé RM; Kelley KW; Dantzer R; Layé S
    Brain Behav Immun; 2008 Feb; 22(2):234-44. PubMed ID: 17905568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogen-activated protein kinase and caspase signaling pathways are required for P2X7 receptor (P2X7R)-induced pore formation in human THP-1 cells.
    Donnelly-Roberts DL; Namovic MT; Faltynek CR; Jarvis MF
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1053-61. PubMed ID: 14634045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. II. Inhibition of IL-1 beta production from ATP-treated monocytes and macrophages.
    Laliberte R; Perregaux D; Svensson L; Pazoles CJ; Gabel CA
    J Immunol; 1994 Sep; 153(5):2168-79. PubMed ID: 8051418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1 beta release from human monocytes.
    Sluyter R; Shemon AN; Wiley JS
    J Immunol; 2004 Mar; 172(6):3399-405. PubMed ID: 15004138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of calcium-insensitive phospholipase A(2) (iPLA(2)) by P2X(7) receptors in murine peritoneal macrophages.
    El Ouaaliti M; Seil M; Dehaye JP
    Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):116-23. PubMed ID: 23041292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential role for Ca2+ in regulation of IL-1beta secretion by P2X7 nucleotide receptor in monocytes, macrophages, and HEK-293 cells.
    Gudipaty L; Munetz J; Verhoef PA; Dubyak GR
    Am J Physiol Cell Physiol; 2003 Aug; 285(2):C286-99. PubMed ID: 12660148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral origin of IL-1beta production in the rodent hippocampus under in vivo systemic bacterial lipopolysaccharide (LPS) challenge and its regulation by P2X(7) receptors.
    Csölle C; Sperlágh B
    J Neuroimmunol; 2010 Feb; 219(1-2):38-46. PubMed ID: 20022387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A key role for redox signaling in rapid P2X7 receptor-induced IL-1 beta processing in human monocytes.
    Hewinson J; Moore SF; Glover C; Watts AG; MacKenzie AB
    J Immunol; 2008 Jun; 180(12):8410-20. PubMed ID: 18523309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release.
    Kahlenberg JM; Dubyak GR
    Am J Physiol Cell Physiol; 2004 May; 286(5):C1100-8. PubMed ID: 15075209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADP and AMP induce interleukin-1beta release from microglial cells through activation of ATP-primed P2X7 receptor channels.
    Chakfe Y; Seguin R; Antel JP; Morissette C; Malo D; Henderson D; Séguéla P
    J Neurosci; 2002 Apr; 22(8):3061-9. PubMed ID: 11943809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-translational processing of murine IL-1: evidence that ATP-induced release of IL-1 alpha and IL-1 beta occurs via a similar mechanism.
    Perregaux DG; Gabel CA
    J Immunol; 1998 Mar; 160(5):2469-77. PubMed ID: 9498792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of monocyte signaling and pore formation in response to agonists of the nucleotide receptor P2X(7).
    Aga M; Johnson CJ; Hart AP; Guadarrama AG; Suresh M; Svaren J; Bertics PJ; Darien BJ
    J Leukoc Biol; 2002 Jul; 72(1):222-32. PubMed ID: 12101284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of P2X7 receptors in rat peritoneal cells.
    Chen YW; Donnelly-Roberts DL; Namovic MT; Gintant GA; Cox BF; Jarvis MF; Harris RR
    Inflamm Res; 2005 Mar; 54(3):119-26. PubMed ID: 15883745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.